- 작성자 : ILIAS Biologics
- 작성일 : 20-07-08 09:52
- 조회 : 411회
7 Jul 2020
ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States
ILIAS Biologics announced today that the company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO). A patent for ILIAS's exosome engineering was previously granted in South Korea by the Korean Intellectual Property Office (KIPO), and the company has applied for the patents in 7 other countries as well. This latest patent is integral to the company's EXPLOR® (EXosome engineering for Protein Loading via Optically Reversible protein–protein interaction) platform technology as well as the Exo-Target® products, as the patent covers not only EXPLOR® technology but also its application for various therapeutic cargo proteins developed by ILIAS for loading into exosomes.